Description Innotox is an innovative botulinum toxin type A developed by the South Korean company Medytox Inc. This product has gained great popularity due to several advantages:
1) Drug structure – Innotox is available in a new liquid phase, so it does not require dilution. One bottle contains the finished product solution for 25, 50 or 100 units.
2) Composition – the improved formula does not contain: proteins, albumin, gelatin compared to other similar botulinum toxins.
3) Temperature conditions – insensitive to temperature changes, unlike solid phase formulations.
4) Diffusion – has the lowest diffusion of all currently known botulinum toxins.
5) Effect – during the treatments, the effect lasts up to 10 months, unlike other botulinum toxins where the effect lasts up to 6 months. Indications – eyelid spasm; – half-face contraction; – cervical dystonia (spastic torticollis); – focal spasticity of the wrist and hand in post-stroke patients; – paralytic strabismus (strabismus); – local muscle spasm in cerebral palsy in children 2 years of age and older; – correction of mimic wrinkles. Brand name: Innotox® Producer: Medytox (South Korea) Application Type: Injection Technique Place Application: face, body Product type: freeze-dried powder Recipe: elimination of mimic wrinkles
Age category: 25+
Skin Type: All skin types
Type of packaging: box with a bottle ACTIVE INGREDIENTS botulinum toxin type A, L-methionine, polysorbate 20, pH 7.0 buffered saline.
■ Active Ingredient - Clostridium botulinum toxin type A (Hall strain)
■ Description - Colorless transparent liquid-filled injection in a colorless transparent vial
■ Storage Condition - Store at 2 ~ 8℃ in a refrigerator, in hermetic container
■ Expiry Date - 36 months from the manufacturing date
■ Indication and Usage - To temporarily improve moderate to severe glabellar wrinkles related to eyebrow wrinkle muscle (corrugator muscle) and/or procerus muscle activity in adults aged from 20 to 65